AbbVie
ABBV
3,782 hedge funds and large institutions have $242B invested in AbbVie in 2025 Q2 according to their latest regulatory filings, with 182 funds opening new positions, 1,705 increasing their positions, 1,469 reducing their positions, and 167 closing their positions.
54% more call options, than puts
Call options by funds: $3.23B | Put options by funds: $2.09B
16% more repeat investments, than reductions
Existing positions increased: 1,705 | Existing positions reduced: 1,469
9% more first-time investments, than exits
New positions opened: 182 | Existing positions closed: 167
0.29% more ownership
Funds ownership: 72.82% → 73.11% (+0.29%)
1% less funds holding
Funds holding: 3,820 → 3,782 (-38)
11% less capital invested
Capital invested by funds: $270B → $242B (-$28.5B)
39% less funds holding in top 10
Funds holding in top 10: 246 → 150 (-96)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$681M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$628M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$552M |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$512M |
| 5 |
JP Morgan Chase
New York
|
+$457M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$1.8B |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.53B |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$1.28B |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$581M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$529M |
ABBV Hedge Fund Activity: Q2 2025 in Review
3,782 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2025, worth a combined $242B — down 11% from $270B a quarter earlier.
Buyers outnumbered sellers: 182 funds opened new ABBV positions and 167 closed out — a net gain of 15 holders — while 1,705 added to existing stakes and 1,469 trimmed.
The largest buyer was Assenagon Asset Management, adding an estimated $681M. The largest seller was Capital World Investors, cutting an estimated $1.8B.
- 3,782 institutional investors held AbbVie (ABBV) as of Q2 2025, down from 3,820 in Q1 2025.
- Funds reported $242B of AbbVie stock for Q2 2025, down 11% quarter-over-quarter.
- 182 funds opened new AbbVie positions in Q2 2025 and 167 closed out, a net change of +15 holders.
- The largest AbbVie buyer in Q2 2025 was Assenagon Asset Management, an estimated $681M added.
- The largest AbbVie seller in Q2 2025 was Capital World Investors, an estimated $1.8B sold.
Based on aggregated 13F filings for Q2 2025.